Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer (Q45237843)

11 December 2017

Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer (English)

1 reference

11 December 2017

0 references

6

1 reference

11 December 2017

Harry Hua-Xiang Xia

1

1 reference

11 December 2017

Yi Yang

2

1 reference

11 December 2017

Kent-Man Chu

3

1 reference

11 December 2017

Qing Gu

4

1 reference

11 December 2017

Yuan-Yuan Zhang

5

1 reference

11 December 2017

Wai Man Wong

7

1 reference

11 December 2017

Suet-Yi Leung

8

1 reference

11 December 2017

Siu-Tsan Yuen

9

1 reference

11 December 2017

Man-Fung Yuen

10

1 reference

11 December 2017

Annie O O Chan

11

1 reference

11 December 2017

Benjamin C Y Wong

12

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

11 December 2017

1 reference

11 December 2017

115

1 reference

11 December 2017

23

1 reference

11 December 2017

5441-5449

1 reference

Mortality by cause for eight regions of the world: Global Burden of Disease Study

11 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Screening for gastric cancer in Asia: current evidence and practice.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Production of macrophage migration inhibitory factor by human and murine neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Protein expression profiles in human breast ductal carcinoma and histologically normal tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Development of chronic colitis is dependent on the cytokine MIF

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Helicobacter pylori infection is associated with increased expression of macrophage migratory inhibitory factor--by epithelial cells, T cells, and macrophages--in gastric mucosa.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Soluble E-cadherin is a valid prognostic marker in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

The two histological main types of gastric carcinoma: diffuse and so called intestinal-type carcinoma: an attempt at a histo-clinical classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

An evaluation of invasive and non-invasive tests for the diagnosis of Helicobacter pylori infection in Chinese

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Carcinoembryonic antigen in gastric cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

American Gastroenterological Association medical position statement: evaluation of dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Role of MIF in inflammation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24609

7 January 2021

Identifiers

DOI

10.1002/CNCR.24609

1 reference

11 December 2017

1 reference